SGLT2 Inhibitors
Cross-source consensus on SGLT2 Inhibitors from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Background
Evidence quality
Other
Highlighted claims
- Median follow-up in the SGLT2i cohort was 1.4 months, substantially shorter than the GLP-1 RA cohort's 2.3 months, driven by later drug launches in China. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- The SGLT2i new-user cohort comprised 935 patients with a mean age of 59.1 years, 61.4% male. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- SGLT2i became broadly available in China after 2017, which directly explains the short follow-up durations and why most eligible patients had index dates outside the 2012–2019 study period. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- The DAPA-CKD trial demonstrated that dapagliflozin reduced kidney and cardiovascular events compared with placebo. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- The high ACS incidence rate in the SGLT2i cohort may be partly explained by diagnostic misclassification when multiple conditions are recorded within a single hospitalisation episode, introducing upward bias in event counts. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China